Data Collection Study of Sporit GG

In-Practice Usage and Performance (IPUP) Study of Sporit GG

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2020/03/023736

Enrollment

300

Registered

2020-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R197- Diarrhea, unspecified

Interventions

Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be eligible for treatment with Sporit GG, as per the treating doctor.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
Duration and frequency of diarrhea.Timepoint: Day 1,2,3,4,5 and 6	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactSachin P

Sun Pharmaceutical Industries Limited

komelabbas.bhojani@sunpharma.com02243244324

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026